HCPCS code Q5122 — Inj, nyvepria.
Status: Active.
Effective Apr 1, 2023.
Source: CMS HCPCS Level II.
Q5122
ActiveInj, nyvepria
Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg
Category:
Temporary
Section:
Q-codes: Temporary Codes
Effective:
Apr 1, 2023
Code type:
alphanumeric
OPPS Status:
K
— Non-pass-through drugs and biologicals
OPPS APC:
9406
MUE — Medically Unlikely Edits
Maximum units of Q5122 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| Outpatient Hospital | 12 |
| Practitioner Services | 12 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 00069-0324-01 | Nyvepria |
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.
-
New Code 2023-Q2Inj, nyvepria